ApolipoproteinA1-75 G/A (M1-) polymorphism and lipoprotein(a); anti- vs. pro-Atherogenic properties
- PMID: 17683612
- PMCID: PMC1995194
- DOI: 10.1186/1476-511X-6-19
ApolipoproteinA1-75 G/A (M1-) polymorphism and lipoprotein(a); anti- vs. pro-Atherogenic properties
Abstract
Background: ApolipoproteinA1 (apoA1) is the major apoprotein constituent of high-density-lipoprotein(HDL). The relationship of apoA1 -75 bp(M1-) allele polymorphism with lipoprotein phenotype and cardiovascular disease (CVD) remain unclear. Overnight fasting blood samples were collected from a cohort of high-risk Omani population, 90 non-diabetic subjects and 149 type 2 diabetes mellitus (T2DM) subjects for genotype and phenotype studies.
Results: The M1+ and M1- alleles frequencies were 0.808 and 0.192 for M1+ and M1-, respectively, comparable to the frequency of apoA1 (M1+ and M1-) amongst a healthy Omani population, 0.788 and 0.212, respectively. The frequencies of the hetero- and homozygous subjects for the MspI polymorphism at -75 (M1-) of the apoA1 gene were in Hardy-Weinberg equilibrium. The mean Lp(a) concentration was significantly higher(P = 0.02) in subjects carrying M1- allele compared to M1+ allele of the APOA1 gene with an odd ratio of 2.3(95% CI, 1.13-14.3), irrespective of gender and the diabetic status.
Conclusion: ApolipoproteinA1-75 G/A (M1-) polymorphism is relatively common and is positively associated with Lp(a) and therefore, may confer a potential risk for cardiovascular disease (CVD).
Similar articles
-
[Association of the hepatic lipase gene -250G/A promoter polymorphism with the susceptibility to type 2 diabetes mellitus combining with coronary heart disease].Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2009 Apr;26(2):219-22. doi: 10.3760/cma.j.issn.1003-9406.2009.02.023. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2009. PMID: 19350521 Chinese.
-
Relationship of apoE polymorphism with lipoprotein(a), apoA, apoB and lipid levels in atherosclerotic infarct.J Neurol Sci. 2009 Feb 15;277(1-2):17-21. doi: 10.1016/j.jns.2008.09.034. Epub 2008 Oct 21. J Neurol Sci. 2009. PMID: 18945448
-
Elevated lipoprotein (a) and apolipoprotein B to AI ratio in South Asian patients with ischaemic stroke.Int J Clin Pract. 2007 Nov;61(11):1824-8. doi: 10.1111/j.1742-1241.2007.01521.x. Int J Clin Pract. 2007. PMID: 17935546
-
Lipoprotein(a): genotype-phenotype relationship and impact on atherogenic risk.Metab Syndr Relat Disord. 2011 Dec;9(6):411-8. doi: 10.1089/met.2011.0026. Epub 2011 Jul 12. Metab Syndr Relat Disord. 2011. PMID: 21749171 Free PMC article. Review.
-
Genetic basis of atherosclerosis: part II: clinical implications.Circulation. 2004 Oct 5;110(14):2066-71. doi: 10.1161/01.CIR.0000143098.98869.F8. Circulation. 2004. PMID: 15466657 Review. No abstract available.
Cited by
-
Truncated variant rs373056577 confers increased risk of type 2 diabetes and missense variant rs121912717 is associated with hypertriglyceridemia in Bangladeshi population.Metabol Open. 2025 Apr 14;26:100364. doi: 10.1016/j.metop.2025.100364. eCollection 2025 Jun. Metabol Open. 2025. PMID: 40292074 Free PMC article.
-
Prediction of dyslipidemia using gene mutations, family history of diseases and anthropometric indicators in children and adolescents: The CASPIAN-III study.Comput Struct Biotechnol J. 2018 Mar 2;16:121-130. doi: 10.1016/j.csbj.2018.02.009. eCollection 2018. Comput Struct Biotechnol J. 2018. PMID: 30026888 Free PMC article.
-
The Effect of Interactions of Single Nucleotide Polymorphisms of APOA1/APOC3 with Food Group Intakes on the Risk of Metabolic Syndrome.Avicenna J Med Biotechnol. 2017 Apr-Jun;9(2):94-103. Avicenna J Med Biotechnol. 2017. PMID: 28496949 Free PMC article.
-
Haplotype analysis of ApoAI gene and sepsis-associated acute lung injury.Lipids Health Dis. 2014 May 13;13:79. doi: 10.1186/1476-511X-13-79. Lipids Health Dis. 2014. PMID: 24885977 Free PMC article.
-
Association of apolipoprotein A1 -75 G/A polymorphism with susceptibility to the development of acute lung injury after cardiopulmonary bypass surgery.Lipids Health Dis. 2013 Nov 11;12:172. doi: 10.1186/1476-511X-12-172. Lipids Health Dis. 2013. PMID: 24209603 Free PMC article.
References
-
- Ascaso JF, Fernanadez-Cru A, Gonazlez Santos P, HernandeZ Mijares A, Mangas Rojas A, Millan J, Felipe Pallardo L, Pedro-Botet J, PereJimene F, Pia G, Pinto X, Plaza I, Rubies-Prat J. Significance of high density lipoprotein-cholesterol in cardiovascular risk prevention: recommendations of the HDL Forum. Am J Cardiovasc Drugs. 2004;4:299–314. doi: 10.2165/00129784-200404050-00003. - DOI - PubMed
-
- Pulkkinen A, Viitanen L, Kareinen A, Lehto S, Laakso M. MspI polymorphism at +83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of HDL cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease. Diabetes Care. 2000;23:791–5. doi: 10.2337/diacare.23.6.791. - DOI - PubMed
-
- Ordovas JM, Corella D, Cupples LA, Demissie S, Kelleher A, Coltell O, Wilson PW, Schaefer FJ, Tucker K. Polyunsaturated fatty acids modulate the effects of the APOA1 G-A polymorphism on HDL-cholesterol concentrations in a sex-specific manner: the Framingham Study. Am J Clin Nutr. 2002;75:38–46. - PubMed
-
- Jeenah M, Kessling A, Miller N, Humphries S. G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations. Mol Biol Med. 1990;7:233–41. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous